Valuation: CALYXTPAR

Market Cap 112M 99.09M 93.74M 84.95M 159M 10.78B 161M 1.12B 432M 5.5B 422M 413M 17.68B P/E 2026 *
-1.02x
P/E 2027 * -1.93x
Enterprise Value 112M 99.09M 93.74M 84.95M 159M 10.78B 161M 1.12B 432M 5.5B 422M 413M 17.68B EV / Sales 2026 *
21.6x
EV / Sales 2027 * 9.04x
Free-Float
73.66%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2026-06-07
Chief Tech/Sci/R&D Officer 57 2013-12-31
Chief Executive Officer 63 2025-02-23
Director TitleAgeSince
Chairman 72 2000-12-31
Director/Board Member 63 2000-12-31
Chairman 82 2025-08-05
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/26 Free

Director

77,586 0.1477%
6/2/26 Free

Chief Executive Officer

77,586 0.1477%
6/2/26 Free

Director

64,748 0.1232%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.93% - - 112M
+0.15%+3.17%+46.39%+35.11% 251B
-0.54%+4.76%+22.33%-8.53% 160B
-0.63%+2.62%-6.56%+39.18% 147B
-0.52%+0.37%-55.31%-17.78% 63.93B
+1.44%-0.29%+15.51%+25.90% 50.05B
-0.10%+8.08%+41.85%+56.28% 49.4B
-0.05%+1.79%-14.59%-19.95% 48.94B
+0.07%+4.56%+51.95%+60.98% 43.52B
+0.04%+13.89%+196.65%+105.52% 41.06B
Average -0.01%+3.21%+33.14%+30.74% 85.43B
Weighted average by Cap. -0.12%+2.72%+27.13%+25.92%

Financials

2026 *2027 *
Net sales 5.19M 4.58M 4.33M 3.93M 7.37M 499M 7.44M 51.81M 19.98M 255M 19.5M 19.08M 817M 12.43M 10.96M 10.37M 9.4M 17.64M 1.19B 17.8M 124M 47.82M 609M 46.67M 45.65M 1.96B
Net income -66.51M -58.66M -55.49M -50.29M -94.37M -6.38B -95.24M -663M -256M -3.26B -250M -244M -10.46B -61.4M -54.16M -51.23M -46.43M -87.12M -5.89B -87.92M -612M -236M -3.01B -231M -226M -9.66B
Net Debt - -
Logo CALYXTPAR
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.470USD
Average target price
14.33USD
Spread / Average Target
+875.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLXT Stock